{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fibrillines : Questions médicales les plus fréquentes",
"headline": "Fibrillines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fibrillines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-24",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fibrillines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de la matrice extracellulaire",
"url": "https://questionsmedicales.fr/mesh/D016326",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de la matrice extracellulaire",
"code": {
"@type": "MedicalCode",
"code": "D016326",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.860.300"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fibrilline-1",
"alternateName": "Fibrillin-1",
"url": "https://questionsmedicales.fr/mesh/D000071838",
"about": {
"@type": "MedicalCondition",
"name": "Fibrilline-1",
"code": {
"@type": "MedicalCode",
"code": "D000071838",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.860.300.400.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibrilline-2",
"alternateName": "Fibrillin-2",
"url": "https://questionsmedicales.fr/mesh/D000071840",
"about": {
"@type": "MedicalCondition",
"name": "Fibrilline-2",
"code": {
"@type": "MedicalCode",
"code": "D000071840",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.860.300.400.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Fibrillines",
"alternateName": "Fibrillins",
"code": {
"@type": "MedicalCode",
"code": "D000071837",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dieter P Reinhardt",
"url": "https://questionsmedicales.fr/author/Dieter%20P%20Reinhardt",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine, Department of Anatomy and Cell Biology, McGill University, Montreal, Canada. dieter.reinhardt@mcgill.ca."
}
},
{
"@type": "Person",
"name": "Clair Baldock",
"url": "https://questionsmedicales.fr/author/Clair%20Baldock",
"affiliation": {
"@type": "Organization",
"name": "Division of Cell-Matrix Biology and Regenerative Medicine, Wellcome Centre for Cell-Matrix Research, The University of Manchester, Manchester, UK."
}
},
{
"@type": "Person",
"name": "Gerhard Sengle",
"url": "https://questionsmedicales.fr/author/Gerhard%20Sengle",
"affiliation": {
"@type": "Organization",
"name": "Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Cologne Center for Musculoskeletal Biomechanics (CCMB), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany."
}
},
{
"@type": "Person",
"name": "Stuart A Cain",
"url": "https://questionsmedicales.fr/author/Stuart%20A%20Cain",
"affiliation": {
"@type": "Organization",
"name": "Division of Cell-Matrix Biology and Regenerative Medicine, Wellcome Centre for Cell-Matrix Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom."
}
},
{
"@type": "Person",
"name": "Muthu L Muthu",
"url": "https://questionsmedicales.fr/author/Muthu%20L%20Muthu",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine, Department of Anatomy and Cell Biology, McGill University, Montreal, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Moderation effects in personality disorder research.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35737564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000582"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of childhood trauma between depressive disorders and personality disorders.",
"datePublished": "2023-07-15",
"url": "https://questionsmedicales.fr/article/37452642",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pmh.1589"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evidence-Based Assessment of Personality Disorder.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37231676",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10731911231176461"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hypnotizability and psychopathology of patients with personality disorders.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35793675",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/00029157.2022.2081125"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD).",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36927130",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10870547231161531"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Scléroprotéines",
"item": "https://questionsmedicales.fr/mesh/D012596"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de la matrice extracellulaire",
"item": "https://questionsmedicales.fr/mesh/D016326"
},
{
"@type": "ListItem",
"position": 6,
"name": "Fibrillines",
"item": "https://questionsmedicales.fr/mesh/D000071837"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fibrillines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fibrillines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fibrillines",
"description": "Comment diagnostiquer une déficience en fibrilline ?\nQuels examens sont utilisés pour évaluer les fibrillines ?\nLes tests génétiques sont-ils fiables pour les fibrillines ?\nQuels symptômes indiquent un problème de fibrilline ?\nPeut-on détecter des anomalies fibrillaires par imagerie ?",
"url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Personality+Disorders&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fibrillines",
"description": "Quels sont les symptômes d'une maladie liée aux fibrillines ?\nLes douleurs articulaires sont-elles liées aux fibrillines ?\nY a-t-il des signes cutanés associés aux fibrillines ?\nLes problèmes oculaires sont-ils fréquents avec les fibrillines ?\nComment les anomalies cardiovasculaires se manifestent-elles ?",
"url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Personality+Disorders&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fibrillines",
"description": "Peut-on prévenir les maladies liées aux fibrillines ?\nY a-t-il des conseils de mode de vie pour les patients fibrillaires ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nComment le suivi médical aide-t-il les patients ?\nLes activités physiques sont-elles sûres pour les patients ?",
"url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Personality+Disorders&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fibrillines",
"description": "Quels traitements existent pour les troubles des fibrillines ?\nLa chirurgie est-elle nécessaire pour les problèmes de fibrillines ?\nDes médicaments peuvent-ils aider les patients fibrillaires ?\nY a-t-il des thérapies spécifiques pour les fibrillines ?\nComment gérer les douleurs liées aux fibrillines ?",
"url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Personality+Disorders&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fibrillines",
"description": "Quelles sont les complications possibles des troubles fibrillaires ?\nLes complications cardiovasculaires sont-elles fréquentes ?\nComment prévenir les complications liées aux fibrillines ?\nLes douleurs chroniques sont-elles une complication courante ?\nLes problèmes respiratoires peuvent-ils être liés aux fibrillines ?",
"url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Personality+Disorders&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fibrillines",
"description": "Quels sont les facteurs de risque pour les troubles des fibrillines ?\nLes antécédents familiaux augmentent-ils le risque ?\nLes mutations génétiques sont-elles un facteur de risque ?\nLes conditions médicales préexistantes influencent-elles le risque ?\nL'âge est-il un facteur de risque pour les troubles fibrillaires ?",
"url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Personality+Disorders&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en fibrilline ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par des tests génétiques et des examens cliniques."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les fibrillines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie, l'IRM et les tests sanguins peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils fiables pour les fibrillines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques sont très fiables pour identifier les mutations des fibrillines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de fibrilline ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs articulaires et des anomalies cardiovasculaires peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies fibrillaires par imagerie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'imagerie peut révéler des anomalies dans les tissus conjonctifs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une maladie liée aux fibrillines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs articulaires, des problèmes cardiaques et des anomalies oculaires."
}
},
{
"@type": "Question",
"name": "Les douleurs articulaires sont-elles liées aux fibrillines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs articulaires peuvent être un signe de dysfonctionnement des fibrillines."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés aux fibrillines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes cutanés comme des vergetures peuvent être observés en cas de déficience en fibrilline."
}
},
{
"@type": "Question",
"name": "Les problèmes oculaires sont-ils fréquents avec les fibrillines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes comme le décollement de la rétine peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les anomalies cardiovasculaires se manifestent-elles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent se manifester par des dilatations aortiques ou des ruptures vasculaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux fibrillines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un suivi médical régulier peut aider à détecter les problèmes tôt."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils de mode de vie pour les patients fibrillaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est recommandé."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque et permettre une surveillance précoce."
}
},
{
"@type": "Question",
"name": "Comment le suivi médical aide-t-il les patients ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suivi médical permet de surveiller l'évolution de la maladie et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles sûres pour les patients ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des activités physiques modérées sont généralement sûres, mais doivent être adaptées à chaque patient."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les troubles des fibrillines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la surveillance, la chirurgie et des médicaments pour gérer les symptômes."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle nécessaire pour les problèmes de fibrillines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie peut être nécessaire pour corriger des anomalies cardiovasculaires graves."
}
},
{
"@type": "Question",
"name": "Des médicaments peuvent-ils aider les patients fibrillaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent aider à gérer les symptômes et à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies spécifiques pour les fibrillines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de thérapie spécifique, mais des soins symptomatiques sont offerts."
}
},
{
"@type": "Question",
"name": "Comment gérer les douleurs liées aux fibrillines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion de la douleur peut inclure des analgésiques et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des troubles fibrillaires ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des ruptures vasculaires, des problèmes cardiaques et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications cardiovasculaires sont courantes et peuvent être graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux fibrillines ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et un traitement approprié peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les douleurs chroniques sont-elles une complication courante ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs chroniques peuvent survenir et nécessitent une gestion adéquate."
}
},
{
"@type": "Question",
"name": "Les problèmes respiratoires peuvent-ils être liés aux fibrillines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes respiratoires peuvent survenir en raison de complications pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des fibrillines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des conditions médicales."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de troubles fibrillaires augmente le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Les mutations génétiques sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations génétiques sont directement liées aux troubles des fibrillines."
}
},
{
"@type": "Question",
"name": "Les conditions médicales préexistantes influencent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme le syndrome de Marfan augmentent le risque de complications."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les troubles fibrillaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge peut influencer la gravité des symptômes, mais n'est pas un facteur de risque direct."
}
}
]
}
]
}
Tests of statistical interactions (or tests of moderation effects) in personality disorder research are a common way for researchers to examine nuanced hypotheses relevant to personality pathology. Ho...
The relationship between childhood trauma with major depressive disorder (MDD) and personality disorders is complex. We explored the differences in the subjective reporting of childhood trauma to dete...
The purpose of this article is to provide a description and discussion of the evidence-based assessment of personality disorder. Considered herein is the assessment of the Section II personality disor...
Assessment of hypnotizability is useful in research and predicting the effects of hypnosis in clinical practice. There are few contemporary scientific reports examining the relationship between hypnot...
To estimate the prevalence of PDs according to Millon's evolution-based model among adult ADHD outpatients....
Cross-sectional study of consecutive patients referred to an adult ADHD clinic. PDs were evaluated with Millon Clinical Multiaxial Inventory-III (MCMI-III)....
One-hundred-eighty-one participants had valid MCMI-III, of whom147 were diagnosed with ADHD. Mean age: 32.97, SD:11.56, females: 74 (50.3%). Among the 147 participants with ADHD, 29 (19.7%) did not me...
Particular personality profiles were more common with different ADHD subtypes. Given the developmental origins of PD, further research may help identify possible links with childhood difficulties....
This systematic review aimed to distil recent literature investigating psychosocial factors which may account for the association between personality disorder (PD) and suicide attempt or suicide death...
Suicide risk is particularly elevated in people with PD compared to those with no, or many other, mental health diagnoses. Despite this, suicide prevention strategies for PD populations have not progr...
Anorexia nervosa (AN) is a highly debilitating disease which frequently results in chronification and often originates in adolescence. Personality traits have been associated with the onset and mainte...
The sample consists of 73 female adolescent patients with AN. We investigated comorbid PD and AN symptom severity performing the International Personality Disorder Examination (IPDE) and the Eating Di...
Almost a third (27.4%) of all participants were diagnosed with comorbid PD. They had significantly higher EDI-2 total scores reflecting overall stronger symptom severity, as well as significantly high...
PD is an important and frequent comorbid condition in adolescent AN and should be addressed in diagnostic and treatment planning. Early diagnosis of comorbidity could have an impact on choosing specia...
Mild traumatic brain injury (mTBI) poses risk to the neurocognitive, emotional, and financial well-being of affected individuals. While aggression and impulsivity have been examined in relation to mTB...
Alexithymia, characterized by difficulty identifying and expressing emotions, is often associated with various psychiatric disorders, including personality disorders (PDs). This study aimed to explore...
A systematic review was conducted following PRISMA guidelines using databases such as MEDLINE (PubMed), Scopus, and Web of Science. The inclusion criteria were studies assessing adults with DSM-5-diag...
From an initial yield of 2434 citations, 20 peer-reviewed articles met the inclusion criteria. The findings indicate a significant association between alexithymia and personality disorders, particular...
These findings underscore the need for integrating alexithymia-focused assessments into clinical practice to enhance therapeutic approaches, allowing for more personalized and effective interventions....
Although previous studies have shown that psychiatric and personality disorders are more prevalent in chronic pain than in pain-free groups, few studies have investigated the prevalence of personality...